TABLE OF CONTENTS
Volume 27, Issue 12 (13 March 2008)
Original Articles
Interference of the dominant negative helix–loop–helix protein ID1 with the proteasomal subunit S5A causes centrosomal abnormalities
J Hasskarl, D S Mern and K Münger
Oncogene 27: 1657-1664; advance online publication, September 24, 2007; doi:10.1038/sj.onc.1210808
Ubiquitylated Tax targets and binds the IKK signalosome at the centrosome
Y Kfoury, R Nasr, A Favre-Bonvin, M El-Sabban, N Renault, M-L Giron, N Setterblad, H El Hajj, E Chiari, A G Mikati, O Hermine, A Saib, H de Thé, C Pique and A Bazarbachi
Oncogene 27: 1665-1676; advance online publication, September 24, 2007; doi:10.1038/sj.onc.1210804
FOXO transcription factor-dependent p15INK4b and p19INK4d expression
K Katayama, A Nakamura, Y Sugimoto, T Tsuruo and N Fujita
Oncogene 27: 1677-1686; advance online publication, September 17, 2007; doi:10.1038/sj.onc.1210813
Involvement of Rab13 and JRAB/MICAL-L2 in epithelial cell scattering
I Kanda, N Nishimura, H Nakatsuji, R Yamamura, H Nakanishi and T Sasaki
Oncogene 27: 1687-1695; advance online publication, September 24, 2007; doi:10.1038/sj.onc.1210812
An N-terminal inhibitory domain modulates activity of FoxM1 during cell cycle
H J Park, Z Wang, R H Costa, A Tyner, L F Lau and P Raychaudhuri
Oncogene 27: 1696-1704; advance online publication, September 24, 2007; doi:10.1038/sj.onc.1210814
CD43 promotes cell growth and helps to evade FAS-mediated apoptosis in non-hematopoietic cancer cells lacking the tumor suppressors p53 or ARF
L Kadaja-Saarepuu, S Laos, K Jääger, J Viil, A Balikova, M Lõoke, G C Hansson and T Maimets
Oncogene 27: 1705-1715; advance online publication, September 24, 2007; doi:10.1038/sj.onc.1210802
Prohibitin interacts with RNF2 and regulates E2F1 function via dual pathways
D Choi, S-J Lee, S Hong, I-H Kim and S Kang
Oncogene 27: 1716-1725; advance online publication, September 17, 2007; doi:10.1038/sj.onc.1210806
S-phase progression stimulates both the mutagenic KU-independent pathway and mutagenic processing of KU-dependent intermediates, for nonhomologous end joining
J Guirouilh-Barbat, S Huck and B S Lopez
Oncogene 27: 1726-1736; advance online publication, September 24, 2007; doi:10.1038/sj.onc.1210807
Essential role of Pyk2 and Src kinase activation in neuropeptide-induced proliferation of small cell lung cancer cells
S Roelle, R Grosse, T Buech, V Chubanov and T Gudermann
Oncogene 27: 1737-1748; advance online publication, October 1, 2007; doi:10.1038/sj.onc.1210819
CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway
S Ma, T K Lee, B-J Zheng, K W Chan and X-Y Guan
Oncogene 27: 1749-1758; advance online publication, September 24, 2007; doi:10.1038/sj.onc.1210811
Ovarian hyperstimulation induces centrosome amplification and aneuploid mammary tumors independently of alterations in p53 in a transgenic mouse model of breast cancer
E L Milliken, K L Lozada, E Johnson, M D Landis, D D Seachrist, I Whitten, A L M Sutton, F W Abdul-Karim and R A Keri
Oncogene 27: 1759-1766; advance online publication, September 24, 2007; doi:10.1038/sj.onc.1210815
Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cells
V Barbetti, A Gozzini, E Rovida, A Morandi, E Spinelli, G Fossati, P Mascagni, M Lübbert, P Dello Sbarba and V Santini
Oncogene 27: 1767-1778; advance online publication, September 24, 2007; doi:10.1038/sj.onc.1210820
Proapoptotic role of Hsp90 by its interaction with c-Jun N-terminal kinase in lipid rafts in edelfosine-mediated antileukemic therapy
T Nieto-Miguel, C Gajate, F González-Camacho and F Mollinedo
Oncogene 27: 1779-1787; advance online publication, September 24, 2007; doi:10.1038/sj.onc.1210816
Short Communications
Widespread deregulation of microRNA expression in human prostate cancer
M Ozen, C J Creighton, M Ozdemir and M Ittmann
Oncogene 27: 1788-1793; advance online publication, September 24, 2007; doi:10.1038/sj.onc.1210809
High-risk human papillomavirus E7 expression reduces cell-surface MHC class I molecules and increases susceptibility to natural killer cells
G Bottley, O G Watherston, Y-L Hiew, B Norrild, G P Cook and G E Blair
Oncogene 27: 1794-1799; advance online publication, September 10, 2007; doi:10.1038/sj.onc.1210798
HPV E6 degradation of p53 and PDZ containing substrates in an E6AP null background
P Massimi, A Shai, P Lambert and L Banks
Oncogene 27: 1800-1804; advance online publication, October 15, 2007; doi:10.1038/sj.onc.1210810
Oncogenomics
Epigenetic regulation of the ras effector/tumour suppressor RASSF2 in breast and lung cancer
W N Cooper, R E Dickinson, A Dallol, E V Grigorieva, T V Pavlova, L B Hesson, I Bieche, M Broggini, E R Maher, E R Zabarovsky, G J Clark and F Latif
Oncogene 27: 1805-1811; advance online publication, September 24, 2007; doi:10.1038/sj.onc.1210805
Corrigendum
Cell type-specific regulation of distinct sets of gene targets by Pax3 and Pax3/FKHR FREE
S Begum, N Emami, A Cheung, O Wilkins, S Der and P A Hamel
Oncogene 27: 1812; doi:10.1038/onc.2008.12
Erratum
Functional characterization of TIP60 sumoylation in UV-irradiated DNA damage response FREE
Z Cheng1, Y Ke, X Ding, F Wang, H Wang, W Wang, K Ahmed, Z Liu, Y Xu, F Aikhionbare, H Yan, J Liu, Y Xue, J Yu, M Powell, S Liang, Q Wu, S E Reddy, R Hu, H Huang, C Jin and X Yao
Oncogene 27: 1812; doi:10.1038/onc.2008.11